These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38651063)

  • 21. JAK inhibitors for the treatment of VEXAS syndrome.
    Bindoli S; Baggio C; Doria A; Bertoldo E; Sfriso P
    Exp Biol Med (Maywood); 2023 May; 248(5):394-398. PubMed ID: 37243340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEXAS syndrome: An update.
    Khitri MY; Hadjadj J; Mekinian A; Jachiet V
    Joint Bone Spine; 2024 Jul; 91(4):105700. PubMed ID: 38307404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
    Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
    Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
    Comont T; Heiblig M; Rivière E; Terriou L; Rossignol J; Bouscary D; Rieu V; Le Guenno G; Mathian A; Aouba A; Vinit J; Dion J; Kosmider O; Terrier B; Georgin-Lavialle S; Fenaux P; Mekinian A;
    Br J Haematol; 2022 Feb; 196(4):969-974. PubMed ID: 34651299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEXAS Syndrome: A Novelty in MDS Landscape.
    Templé M; Kosmider O
    Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist.
    Sterling D; Duncan ME; Philippidou M; Salisbury JR; Kulasekararaj AG; Basu TN
    J Am Acad Dermatol; 2023 Dec; 89(6):1209-1214. PubMed ID: 35121074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis.
    Martinelli I; Bucciarelli P; Passamonti SM; Battaglioli T; Previtali E; Mannucci PM
    Circulation; 2010 Jun; 121(25):2740-6. PubMed ID: 20547928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.
    Kunishita Y; Kirino Y; Tsuchida N; Maeda A; Sato Y; Takase-Minegishi K; Yoshimi R; Nakajima H
    Front Immunol; 2022; 13():901063. PubMed ID: 35769485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings.
    Hines AS; Mohandesi NA; Lehman JS; Koster MJ; Cantwell HM; Alavi A; Warrington KJ; Mangaonkar AA; Go RS; Patnaik MM; Sartori-Valinotti JC
    Int J Dermatol; 2023 Jul; 62(7):938-945. PubMed ID: 36890121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lesion probability map in cerebral vein thrombosis due to Behçet's disease.
    Emekli AS; Doğan FU; Gündüz T; Sezgin M; Ekizoğlu E; Yeşilot N; Çoban O; Akman G; Kürtüncü M
    Int J Rheum Dis; 2023 Jan; 26(1):145-150. PubMed ID: 36210482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEXAS syndrome: A new mimicker of idiopathic multicentric Castleman disease.
    Philip R; Cadro V; Aouba A; Chantepie S; Bracquemart C; Dumont A
    Joint Bone Spine; 2024 Jul; 91(4):105731. PubMed ID: 38583690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on VEXAS syndrome.
    Al-Hakim A; Savic S
    Expert Rev Clin Immunol; 2023 Feb; 19(2):203-215. PubMed ID: 36537591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Challenges of Emerging Acquired Autoinflammatory Diseases, Including VEXAS Syndrome.
    Kirino Y
    Intern Med; 2024 Feb; ():. PubMed ID: 38296470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEXAS syndrome: Clinical manifestations, diagnosis, and treatment.
    Loeza-Uribe MP; Hinojosa-Azaola A; Sánchez-Hernández BE; Crispín JC; Apodaca-Chávez E; Ferrada MA; Martín-Nares E
    Reumatol Clin (Engl Ed); 2024 Jan; 20(1):47-56. PubMed ID: 38160120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The VEXAS Syndrome: Uncontrolled Inflammation and Macrocytic Anaemia in a 77-Year-Old Male Patient.
    Himmelmann A; Brücker R
    Eur J Case Rep Intern Med; 2021; 8(4):002484. PubMed ID: 33987129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasculitis associated with VEXAS syndrome: A literature review.
    Watanabe R; Kiji M; Hashimoto M
    Front Med (Lausanne); 2022; 9():983939. PubMed ID: 36045928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome-clinical presentation of a newly described somatic, autoinflammatory syndrome.
    Alhomida F; Beck DB; George TI; Shaffer A; Lebiedz-Odrobina D; Kovacsovics T; Madigan LM
    JAAD Case Rep; 2021 Aug; 14():111-113. PubMed ID: 34337120
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebral venous sinus thrombosis in Behçet's disease: a retrospective case-control study.
    Shi J; Huang X; Li G; Wang L; Liu J; Xu Y; Zeng X; Zheng W
    Clin Rheumatol; 2018 Jan; 37(1):51-57. PubMed ID: 28612244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Long-Term Outcomes for Patients with Budd-Chiari Syndrome Caused by Behcet's Disease: A Case Series on the Results, from Cirrhosis to Death.
    Cansu DU; Temel T; Erturk A; Kasifoglu T; Acu B; Korkmaz C
    Hepat Mon; 2016 Oct; 16(10):e32457. PubMed ID: 27882061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.
    de Valence B; Delaune M; Nguyen Y; Jachiet V; Heiblig M; Jean A; Riescher Tuczkiewicz S; Henneton P; Guilpain P; Schleinitz N; Le Guenno G; Lobbes H; Lacombe V; Ardois S; Lazaro E; Langlois V; Outh R; Vinit J; Martellosio JP; Decker P; Moulinet T; Dieudonné Y; Bigot A; Terriou L; Vlakos A; de Maleprade B; Denis G; Broner J; Kostine M; Humbert S; Lifermann F; Samson M; Pechuzal S; Aouba A; Kosmider O; Dion J; Grosleron S; Bourguiba R; Terrier B; Georgin-Lavialle S; Fain O; Mekinian A; Morgand M; Comont T; Hadjadj J;
    Ann Rheum Dis; 2024 Feb; 83(3):372-381. PubMed ID: 38071510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.